Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
NCT06496256
This study is recruiting at 7 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
Barrigel is intended to temporarily position the anterior rectal wall away from the prostate or prostate bed during radiotherapy treatment for prostate cancer and, in creating this space, it is the intent of Barrigel to reduce the radiation dose delivered to the anterior rectum.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Prostate Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- Male
- Healthy volunteers
- Not accepted
- Sponsor
- Palette Life Sciences, Inc.
- Last updated on ClinicalTrials.gov
- September 28, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Baptist Health South Florida Inc · Boca Raton, FL
Georgia · 1
- Augusta University Research Institute · Augusta, GA
Massachusetts · 1
- Dana Farber Cancer Institute · Boston, MA
New Jersey · 1
- Summit Health · Clifton, NJ
Ohio · 1
- University Hospitals Cleveland Medical Center · Cleveland, OH
Texas · 1
- Urology Austin · Austin, TX
Virginia · 1
- Virginia Urology Center · Richmond, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.